Infant,Premature
21
0
2
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
14.3%
3 terminated out of 21 trials
78.6%
-7.9% vs benchmark
14%
3 trials in Phase 3/4
64%
7 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (21)
Serial Assessment of Body Fat Accrual in Very Preterm Infants
Oxygenation Instability and Maturation of Control of Breathing in Premature Infants
Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
Baby-CINO: CaffeINe Treatment Optimisation in Premature Infants
Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants
Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy
Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia
Personalized vs Standardized PN for Preterm Infants >1250g
Use of Prokinetics in Early Enteral Feeding in Preterm Infants
Movement-based Infant Intervention
Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 3
Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2
Improving Right Ventricular Function in Young Adults Born Preterm
Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI)
Non-nutritive Sucking and Breastfeeding in Preterm Infants
Impact of Protein Supplementation to Mother Milk on Resting Energy Expenditure (REE) in Growing Healthy Preterm Infants.
Comparison of Leakage With Nasal Prongs and Nasal Mask Interface in Newborns Receiving CPAP Treatment
Nifty Feeding Cup Versus Generic Medicine Cup Preterm Infants Who Have Difficulty Breastfeeding
Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.